Key Takeaways PacBio's Q3 loss per share narrowed to 12 cents, topping earnings estimates despite lower sales.Revenues fell 3.8% year over year to $38.4M, hurt by weaker instrument shipments and pricing.Consumables and service revenues rose in double digits, boosting margins and trimming operating loss.Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 12 cents in third-quarter 2025, narrower than the year-ago adjusted loss of 17 cents per sha ...